The GB COVID-19 nucleocapsid Ag Point-of-Care Test (POCT) is intended for the qualitative detection of COVID-19 antigen from nasopharyngeal swab specimen.
For qualitative detection of antibodies to SARS-CoV-2 virus (anti-SARS-CoV-2) in human serum or plasma
For use with One tube, detection for SARS-CoV-2, influenza A and influenza B
An Enzyme Immunoassay (ELISA) kit for in vitro Semi-Quantitative the detection of IgG abd IgM antibodies to SARS-CoV-2 in human serum/plasma
For Oral, Throat and Nasopharyngeal sampling of virus
For isolation of viral RNA/ viral nucleic acid from cell-free fluid such as, serum, plasma, body fluid and cell culture supernatant, and from transport medium of swabs
For in-vitro Qualitative Detection of 2019-Novel Coronavirus in Human Respiratory Specimens
For in-vitro Qualitative Detection of 2019-Novel Coronavirus in Human